Loading clinical trials...
Loading clinical trials...
A randomized multicentric parallel arms study involving the use of ketamine for treatment-resistant depression will be held at three national health provider clinics in the Mexican population. The pur...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Paul J. Lamothe
NCT07227454 · Depressive Disorder, Major
NCT06860958 · Depressive Disorder, Major
NCT07274917 · Treatment-Resistant Depression, Depressive Disorder
NCT07412756 · Depressive Disorder, Major
NCT06780917 · Mild Cognitive Impairment (MCI), Major Depressive Disorder, Remitted, and more
ABC Neurological Center
Mexico City, Mexico City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions